Global Prostate-Specific Antigen (PSA) Test Market Size, Status and Forecast 2020-2026

May 2020 | 91 pages | ID: G0D8A5883305EN
QYResearch

Abstracts

This report focuses on the global Prostate-Specific Antigen (PSA) Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate-Specific Antigen (PSA) Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Abbott
• Siemens Healthcare
• DiaSorin
• Roche
• Beckman Coulter
• PerkinElmer
• Tosoh
• Ortho Clinical
• Fujirebio
• Mediwatch (LABORIE)
• BodiTech

Market segment by Type, the product can be split into

• CLIA
• ELISA
• Other

Market segment by Application, split into

• Screening
• Post-treatment Monitoring
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Prostate-Specific Antigen (PSA) Test status, future forecast, growth opportunity, key market and key players.
• To present the Prostate-Specific Antigen (PSA) Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Prostate-Specific Antigen (PSA) Test are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
1.4 Market Analysis by Type
  1.4.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CLIA
  1.4.3 ELISA
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2020 VS 2026
  1.5.2 Screening
  1.5.3 Post-treatment Monitoring
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Prostate-Specific Antigen (PSA) Test Market Perspective (2015-2026)
2.2 Prostate-Specific Antigen (PSA) Test Growth Trends by Regions
  2.2.1 Prostate-Specific Antigen (PSA) Test Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Share by Regions (2015-2020)
  2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Prostate-Specific Antigen (PSA) Test Market Growth Strategy
  2.3.6 Primary Interviews with Key Prostate-Specific Antigen (PSA) Test Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Market Size
  3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2015-2020)
  3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2015-2020)
  3.1.3 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio
  3.2.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2019
3.3 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served
3.4 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
3.5 Date of Enter into Prostate-Specific Antigen (PSA) Test Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2015-2020)
4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2021-2026)

5 PROSTATE-SPECIFIC ANTIGEN (PSA) TEST BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)
5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
6.2 Prostate-Specific Antigen (PSA) Test Key Players in North America (2019-2020)
6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
7.2 Prostate-Specific Antigen (PSA) Test Key Players in Europe (2019-2020)
7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

8 CHINA

8.1 China Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
8.2 Prostate-Specific Antigen (PSA) Test Key Players in China (2019-2020)
8.3 China Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
8.4 China Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
9.2 Prostate-Specific Antigen (PSA) Test Key Players in Japan (2019-2020)
9.3 Japan Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
9.4 Japan Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
10.2 Prostate-Specific Antigen (PSA) Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

11 INDIA

11.1 India Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
11.2 Prostate-Specific Antigen (PSA) Test Key Players in India (2019-2020)
11.3 India Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
11.4 India Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
12.2 Prostate-Specific Antigen (PSA) Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
12.4 Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
  13.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020))
  13.1.5 Abbott Recent Development
13.2 Siemens Healthcare
  13.2.1 Siemens Healthcare Company Details
  13.2.2 Siemens Healthcare Business Overview and Its Total Revenue
  13.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
  13.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.2.5 Siemens Healthcare Recent Development
13.3 DiaSorin
  13.3.1 DiaSorin Company Details
  13.3.2 DiaSorin Business Overview and Its Total Revenue
  13.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
  13.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.3.5 DiaSorin Recent Development
13.4 Roche
  13.4.1 Roche Company Details
  13.4.2 Roche Business Overview and Its Total Revenue
  13.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
  13.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.4.5 Roche Recent Development
13.5 Beckman Coulter
  13.5.1 Beckman Coulter Company Details
  13.5.2 Beckman Coulter Business Overview and Its Total Revenue
  13.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
  13.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.5.5 Beckman Coulter Recent Development
13.6 PerkinElmer
  13.6.1 PerkinElmer Company Details
  13.6.2 PerkinElmer Business Overview and Its Total Revenue
  13.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
  13.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.6.5 PerkinElmer Recent Development
13.7 Tosoh
  13.7.1 Tosoh Company Details
  13.7.2 Tosoh Business Overview and Its Total Revenue
  13.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
  13.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.7.5 Tosoh Recent Development
13.8 Ortho Clinical
  13.8.1 Ortho Clinical Company Details
  13.8.2 Ortho Clinical Business Overview and Its Total Revenue
  13.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
  13.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.8.5 Ortho Clinical Recent Development
13.9 Fujirebio
  13.9.1 Fujirebio Company Details
  13.9.2 Fujirebio Business Overview and Its Total Revenue
  13.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
  13.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.9.5 Fujirebio Recent Development
13.10 Mediwatch (LABORIE)
  13.10.1 Mediwatch (LABORIE) Company Details
  13.10.2 Mediwatch (LABORIE) Business Overview and Its Total Revenue
  13.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
  13.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  13.10.5 Mediwatch (LABORIE) Recent Development
13.11 BodiTech
  10.11.1 BodiTech Company Details
  10.11.2 BodiTech Business Overview and Its Total Revenue
  10.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
  10.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  10.11.5 BodiTech Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Prostate-Specific Antigen (PSA) Test Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
Table 3. Ranking of Global Top Prostate-Specific Antigen (PSA) Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CLIA
Table 6. Key Players of ELISA
Table 7. Key Players of Other
Table 8. Global Prostate-Specific Antigen (PSA) Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Prostate-Specific Antigen (PSA) Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Prostate-Specific Antigen (PSA) Test Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Prostate-Specific Antigen (PSA) Test Market Share by Regions (2015-2020)
Table 12. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Prostate-Specific Antigen (PSA) Test Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Prostate-Specific Antigen (PSA) Test Market Growth Strategy
Table 18. Main Points Interviewed from Key Prostate-Specific Antigen (PSA) Test Players
Table 19. Global Prostate-Specific Antigen (PSA) Test Revenue by Players (2015-2020) (Million US$)
Table 20. Global Prostate-Specific Antigen (PSA) Test Market Share by Players (2015-2020)
Table 21. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2019)
Table 22. Global Prostate-Specific Antigen (PSA) Test by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
Table 25. Date of Enter into Prostate-Specific Antigen (PSA) Test Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 28. Global Prostate-Specific Antigen (PSA) Test Market Size Share by Type (2015-2020)
Table 29. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2021-2026)
Table 30. Global Prostate-Specific Antigen (PSA) Test Market Size Share by Application (2015-2020)
Table 31. Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 32. Global Prostate-Specific Antigen (PSA) Test Market Size Share by Application (2021-2026)
Table 33. North America Key Players Prostate-Specific Antigen (PSA) Test Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Prostate-Specific Antigen (PSA) Test Market Share (2019-2020)
Table 35. North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 36. North America Prostate-Specific Antigen (PSA) Test Market Share by Type (2015-2020)
Table 37. North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 38. North America Prostate-Specific Antigen (PSA) Test Market Share by Application (2015-2020)
Table 39. Europe Key Players Prostate-Specific Antigen (PSA) Test Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Prostate-Specific Antigen (PSA) Test Market Share (2019-2020)
Table 41. Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Prostate-Specific Antigen (PSA) Test Market Share by Type (2015-2020)
Table 43. Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Prostate-Specific Antigen (PSA) Test Market Share by Application (2015-2020)
Table 45. China Key Players Prostate-Specific Antigen (PSA) Test Revenue (2019-2020) (Million US$)
Table 46. China Key Players Prostate-Specific Antigen (PSA) Test Market Share (2019-2020)
Table 47. China Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 48. China Prostate-Specific Antigen (PSA) Test Market Share by Type (2015-2020)
Table 49. China Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 50. China Prostate-Specific Antigen (PSA) Test Market Share by Application (2015-2020)
Table 51. Japan Key Players Prostate-Specific Antigen (PSA) Test Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Prostate-Specific Antigen (PSA) Test Market Share (2019-2020)
Table 53. Japan Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Prostate-Specific Antigen (PSA) Test Market Share by Type (2015-2020)
Table 55. Japan Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Prostate-Specific Antigen (PSA) Test Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Prostate-Specific Antigen (PSA) Test Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Prostate-Specific Antigen (PSA) Test Market Share (2019-2020)
Table 59. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Share by Type (2015-2020)
Table 61. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Share by Application (2015-2020)
Table 63. India Key Players Prostate-Specific Antigen (PSA) Test Revenue (2019-2020) (Million US$)
Table 64. India Key Players Prostate-Specific Antigen (PSA) Test Market Share (2019-2020)
Table 65. India Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 66. India Prostate-Specific Antigen (PSA) Test Market Share by Type (2015-2020)
Table 67. India Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 68. India Prostate-Specific Antigen (PSA) Test Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Prostate-Specific Antigen (PSA) Test Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Prostate-Specific Antigen (PSA) Test Market Share (2019-2020)
Table 71. Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Prostate-Specific Antigen (PSA) Test Market Share by Type (2015-2020)
Table 73. Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Prostate-Specific Antigen (PSA) Test Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Siemens Healthcare Company Details
Table 81. Siemens Healthcare Business Overview
Table 82. Siemens Healthcare Product
Table 83. Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 84. Siemens Healthcare Recent Development
Table 85. DiaSorin Company Details
Table 86. DiaSorin Business Overview
Table 87. DiaSorin Product
Table 88. DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 89. DiaSorin Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Beckman Coulter Company Details
Table 96. Beckman Coulter Business Overview
Table 97. Beckman Coulter Product
Table 98. Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 99. Beckman Coulter Recent Development
Table 100. PerkinElmer Company Details
Table 101. PerkinElmer Business Overview
Table 102. PerkinElmer Product
Table 103. PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 104. PerkinElmer Recent Development
Table 105. Tosoh Company Details
Table 106. Tosoh Business Overview
Table 107. Tosoh Product
Table 108. Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 109. Tosoh Recent Development
Table 110. Ortho Clinical Business Overview
Table 111. Ortho Clinical Product
Table 112. Ortho Clinical Company Details
Table 113. Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 114. Ortho Clinical Recent Development
Table 115. Fujirebio Company Details
Table 116. Fujirebio Business Overview
Table 117. Fujirebio Product
Table 118. Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 119. Fujirebio Recent Development
Table 120. Mediwatch (LABORIE) Company Details
Table 121. Mediwatch (LABORIE) Business Overview
Table 122. Mediwatch (LABORIE) Product
Table 123. Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 124. Mediwatch (LABORIE) Recent Development
Table 125. BodiTech Company Details
Table 126. BodiTech Business Overview
Table 127. BodiTech Product
Table 128. BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020) (Million US$)
Table 129. BodiTech Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Prostate-Specific Antigen (PSA) Test Market Share by Type: 2020 VS 2026
Figure 2. CLIA Features
Figure 3. ELISA Features
Figure 4. Other Features
Figure 5. Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2020 VS 2026
Figure 6. Screening Case Studies
Figure 7. Post-treatment Monitoring Case Studies
Figure 8. Other Case Studies
Figure 9. Prostate-Specific Antigen (PSA) Test Report Years Considered
Figure 10. Global Prostate-Specific Antigen (PSA) Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prostate-Specific Antigen (PSA) Test Market Share by Regions: 2020 VS 2026
Figure 12. Global Prostate-Specific Antigen (PSA) Test Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prostate-Specific Antigen (PSA) Test Market Share by Players in 2019
Figure 15. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue in 2019
Figure 17. North America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Abbott Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 26. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Siemens Healthcare Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 28. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. DiaSorin Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 32. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Beckman Coulter Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 34. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. PerkinElmer Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 36. Tosoh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Tosoh Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 38. Ortho Clinical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Ortho Clinical Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 40. Fujirebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Fujirebio Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 42. Mediwatch (LABORIE) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Mediwatch (LABORIE) Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 44. BodiTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. BodiTech Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed